Valproic Acid Treatment Rescues Injured Tissues After Traumatic Brain Injury

BACKGROUND: No agents that are specifically neuroprotective are currently approved to emergently treat patients with traumatic brain injury (TBI). The histone deacetylase inhibitor, high-dose valproic acid (VPA) has been shown to have cytoprotective potential in models of combined TBI and hemorrhagi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Trauma Acute Care Surg
Autors principals: Biesterveld, Ben E., Pumiglia, Luke, Iancu, Ariella, Shamshad, Alizeh A., Remmer, Henriette A., Siddiqui, Ali Z., O’Connell, Rachel L., Wakam, Glenn K., Kemp, Michael T., Williams, Aaron M., Pai, Manjunath P., Alam, Hasan B.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830776/
https://ncbi.nlm.nih.gov/pubmed/32890344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TA.0000000000002918
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars